The Younger Lab is actively searching for highly motivated PhD-level scientists to join our technology development efforts towards building a first-of-its-kind functional precision medicine platform. Leveraging our recently described platform for the scalable production of patient-specific iPSC-derived organoid models (published in Nature), we're now developing individualized cellular technologies for modeling/predicting patient-specific therapeutic responses. See the video for an example of how projects in our lab are translating directly to the clinic.

The objective of this role is to expand the scope of individualized cellular technologies at Children's Mercy, with an emphasis on clinically facing applications. This role will be responsible for the standardization and clinical implementation of therapeutic screening in patient-derived organoid models. Current focus areas include refinement of organoid production pipelines, methods development for high-throughput organoid phenotyping, and optimization of therapeutic screening strategies.

Ideal applicants will have a PhD in molecular biology, genetics, or a related field. Experience working with mammalian cell culture is required. Candidates that have hands-on experience working with stem cell models are highly encouraged to apply.

The Younger Lab is affiliated with the Children's Mercy Research Institute at Children's Mercy Hospital, the Department of Pediatrics at the University of Kansas Medical Center, and the University of Missouri-Kansas City School of Medicine.